SELLAS Life Sciences Grou... (SLS)
1.17
-0.01 (-0.85%)
At close: Mar 03, 2025, 3:59 PM
1.17
0.43%
After-hours: Mar 03, 2025, 04:29 PM EST
SELLAS Life Sciences Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -37.34M | -41.3M | -20.7M | -16.76M | -19.29M | -27.67M | -23.75M | -11.1M | -38.96M | -36.61M | -76.68M | -34.97M | -11.48M | -11.99M | -18.39M | -14.37M | -10.99M | -2.4M |
| Depreciation & Amortization | n/a | 457K | 5.68M | 282K | 1.7M | 3.76M | n/a | 142K | 355K | 889K | 452K | 49K | 163K | 172K | 162K | 131K | 36K | n/a |
| Stock-Based Compensation | 1.39M | 1.73M | 1.01M | 578K | 573K | 395K | 3.17M | 2.26M | 1.93M | 5.39M | 2.53M | 1.39M | 3M | 4.37M | 4.2M | n/a | n/a | n/a |
| Other Working Capital | 1.04M | 4.43M | -5.1M | 6.43M | -1.12M | -2.07M | -2.3M | -24.16M | 20.16M | 3M | 5.89M | -535K | 2.06M | 213K | 54K | -344K | 753K | -181K |
| Other Non-Cash Items | 1.2M | 10.13M | -4.16M | -87K | 586K | 4.42M | 3.53M | -11.55M | -31.73M | -170K | 41.23M | 13.51M | -21.29M | -3.12M | 1.97M | 4.82M | 4.23M | 474K |
| Deferred Income Tax | n/a | -457K | -239K | -23K | -95K | -1.32M | n/a | 243K | 365K | -16.36M | 1.05M | -1.05M | 12.39M | n/a | 4K | n/a | n/a | n/a |
| Change in Working Capital | 3.35M | 5.64M | -7.62M | 5.59M | -1.11M | -10.01M | 6.07M | -24.91M | 19.87M | 3.99M | 2.51M | 106K | 2.56M | 312K | 285K | -5K | 674K | -181K |
| Operating Cash Flow | -31.41M | -23.81M | -26.02M | -10.42M | -17.64M | -30.42M | -10.99M | -44.91M | -48.16M | -42.87M | -28.91M | -20.96M | -14.67M | -10.26M | -11.77M | -9.43M | -6.05M | -2.11M |
| Capital Expenditures | -5.5M | -4.5M | n/a | n/a | n/a | n/a | n/a | -6K | -153K | -5.53M | -15.85M | n/a | -53K | -106K | -83K | -166K | -229K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 1.81M | n/a | n/a | n/a | n/a | -87K | 168K | 106K | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.99M | n/a | -19.79M | -11.76M | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.91M | n/a | n/a | 5.99M | n/a | 29.53M | 1.98M | n/a |
| Other Investing Acitivies | -5.5M | -4.5M | n/a | n/a | n/a | n/a | n/a | -1.05M | 10.55M | -5.53M | -99K | -87K | -101K | -106K | n/a | 21K | -16K | n/a |
| Investing Cash Flow | -5.5M | -4.5M | n/a | n/a | n/a | n/a | 1.81M | -1.06M | 10.39M | -5.53M | -12.04M | -87K | 14K | -106K | -83K | 9.6M | -10.03M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -7.6M | -473K | 16.5M | -3.91M | -1.77M | 9.87M | 500K | 416K | -70K | -34K | -22K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.85M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | -487K | -675K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 90K | 85K | 3.07M | 8.84M | 3.6M | 9.65M | n/a | n/a | 31K | 15.06M | 8.36M | 5.45M | 150K | 254K | n/a | 26K | 2M | 2.11M |
| Financial Cash Flow | 22.32M | 24.08M | 12.07M | 38.44M | 19.57M | 23.12M | 5.53M | 34.32M | 43.84M | 24.26M | 55.92M | 42.42M | 19.2M | 11.57M | 7.68M | 7.92M | 17.83M | 2.11M |
| Net Cash Flow | -14.6M | -4.23M | -13.95M | 28.02M | 1.93M | -7.3M | -3.64M | -11.65M | 6.08M | -24.14M | 14.98M | 21.37M | 4.54M | 1.21M | -4.17M | 8.09M | 1.76M | n/a |
| Free Cash Flow | -36.91M | -28.31M | -26.02M | -10.42M | -17.64M | -30.42M | -10.99M | -44.92M | -48.31M | -48.4M | -44.76M | -20.96M | -14.72M | -10.36M | -11.85M | -9.6M | -6.28M | -2.11M |